Sarcoidosis drug study halted after just 3 patients
Disease control
Terminated
This study looked at whether the drug maraviroc could reduce inflammation in the lungs of people with sarcoidosis. Three participants took the drug for 6 weeks and had lung fluid tests before and after. The study was stopped early, so results are limited.
Phase: NA • Sponsor: Kevin F. Gibson • Aim: Disease control
Last updated May 15, 2026 11:53 UTC